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Nicky Konstantopoulos2, Andrew Sanigorski2, Paul Della Gatta1, David Cameron-Smith3,
Anastasia Kralli4 and Aaron P. Russell1
1 Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Burwood, VIC,
Australia, 2 School of Medicine, Deakin University, Waurn Ponds, VIC, Australia, 3 Liggins Institute, University of Auckland,
Auckland, New Zealand, 4 Department of Physiology, School of Medicine, Johns Hopkins University, Baltimore, MD,
United States
The transcriptional coactivators peroxisome proliferator-activated receptor-γ
coactivator-1α (PGC-1α) and PGC-1β are positive regulators of skeletal muscle mass
and energy metabolism; however, whether they influence muscle growth and metabolic
adaptations via increased protein synthesis is not clear. This study revealed PGC-1α or
PGC-1β overexpression in C2C12 myotubes increased protein synthesis and myotube
diameter under basal conditions and attenuated the loss in protein synthesis following
the treatment with the catabolic agent, dexamethasone. To investigate whether PGC-
1α or PGC-1β signal through the Akt/mTOR pathway to increase protein synthesis,
treatment with the PI3K and mTOR inhibitors, LY294002 and rapamycin, respectively,
was undertaken but found unable to block PGC-1α or PGC-1β’s promotion of protein
synthesis. Furthermore, PGC-1α and PGC-1β decreased phosphorylation of Akt and
the Akt/mTOR substrate, p70S6K. In contrast to Akt/mTOR inhibition, the suppression
of ERRα, a major effector of PGC-1α and PGC-1β activity, attenuated the increase
in protein synthesis and myotube diameter in the presence of PGC-1α or PGC-1β
overexpression. To characterize further the biological processes occurring, gene set
enrichment analysis of genes commonly regulated by both PGC-1α and PGC-1β was
performed following a microarray screen. Genes were found enriched in metabolic
and mitochondrial oxidative processes, in addition to protein translation and muscle
development categories. This suggests concurrent responses involving both increased
metabolism and myotube protein synthesis. Finally, based on their known function or
unbiased identification through statistical selection, two sets of genes were investigated
in a human exercise model of stimulated protein synthesis to characterize further the
genes influenced by PGC-1α and PGC-1β during physiological adaptive changes in
skeletal muscle.
Keywords: PGC-1α, PGC-1β, ERRα, protein synthesis, C2C12 myotubes, muscle mass, metabolism, resistance
exercise
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INTRODUCTION
The significant reduction in skeletal muscle mass known
as atrophy occurs as a consequence of protein catabolism
outweighing protein synthesis rates (reviewed in Favier et al.,
2008; Huang and Zhu, 2016) with mitochondrial dysfunction
potentially contributing to muscle atrophy (Romanello et al.,
2010; Russell et al., 2014). Severe muscle atrophy can lead to
debilitating consequences including loss in strength, mobility,
and independence, and increased morbidity and mortality as
an outcome from sustained inactivity, increasing age, and
systemic diseases (reviewed in Kalyani et al., 2014). The
transcriptional coactivators, peroxisome proliferator-activated
receptor-γ coactivator-1α (PGC-1α) and PGC-1β, contribute to
the control of skeletal muscle mass and energy metabolism
through their coordinated transcriptional regulation of genes
involved in mitochondrial biogenesis and fusion (Wu et al.,
1999; St-Pierre et al., 2003; Schreiber et al., 2004; Soriano et al.,
2006; Liesa et al., 2008; Shao et al., 2010), protection against
protein degradation (Brault et al., 2010), skeletal muscle fiber type
determination (Lin et al., 2002; Arany et al., 2007; Rasbach et al.,
2010), glucose transport (Michael et al., 2001; Kelly et al., 2009),
creatine uptake (Brown et al., 2014), lipid oxidation (Benton
et al., 2008; Espinoza et al., 2010), and angiogenesis (Arany
et al., 2008; Rowe et al., 2011). The expression of PGC-1α and/or
PGC-1β is reduced in conditions associated with skeletal muscle
atrophy and perturbed metabolic function, such as aging (Ling
et al., 2004; Rodriguez-Calvo et al., 2006; Joseph et al., 2012),
denervation (Sandri et al., 2006; Sacheck et al., 2007), heart failure
(Garnier et al., 2003; Vescovo et al., 2005), sepsis (Menconi
et al., 2010), cancer cachexia and renal failure (Sandri et al.,
2006), amyotrophic lateral sclerosis (ALS; Russell et al., 2013),
insulin-resistance, and diabetes (Mootha et al., 2003; Patti et al.,
2003).
To extend these findings, the overexpression of PGC-1α
or PGC-1β in mouse skeletal muscle was found protective
against muscle mass loss following denervation, fasting, and
hindlimb unloading (Sandri et al., 2006; Brault et al., 2010;
Cannavino et al., 2014, 2015) and in a model of Duchenne
muscular dystrophy (DMD; Handschin et al., 2007; Selsby et al.,
2012). Furthermore, PGC-1α attenuated muscle atrophy by
maintaining mitochondrial biogenesis during the on-set and
progression of ALS (Da Cruz et al., 2012). One mechanism
known to cause a decrease in protein degradation following
PGC-1α or PGC-1β overexpression is via the attenuation of
FOXO3a transcriptional activity (Sandri et al., 2006; Brault
et al., 2010). In addition, PGC-1α prevented hindlimb unloading
atrophy by reducing autophagy, proteasome degradation, and
maintaining mitochondrial dynamics (Cannavino et al., 2014,
2015). Previously, PGC-1α and PGC-1β overexpression in vitro
has been suggested not to increase protein synthesis (Brault
et al., 2010); however, rodent and cell culture studies identified
a specific isoform of PGC-1α, PGC-1α4, to stimulate muscle
hypertrophy via induction of insulin-like growth factor-1 (IGF-
1) and repression of myostatin (Ruas et al., 2012), positive and
negative regulators of protein synthesis, respectively (Taylor et al.,
2001; Quinn et al., 2007). In humans, it is unclear whether
specific or all isoforms of PGC-1α promote a hypertrophic
response to either acute resistant or endurance training
(Ydfors et al., 2013; Lundberg et al., 2014). Therefore, a clear
role for PGC-1α and PGC-1β in regulating skeletal muscle
protein synthesis requires further investigation to understand
their contribution to muscle fiber hypertrophy and metabolic
adaptations.
Many of the PGC-1α and/or PGC-1β-mediated effects
on skeletal muscle involve their activation of the orphan
nuclear receptor, estrogen-related receptor alpha (ERRα).
ERRα is required for PGC-1α and/or PGC-1β to increase
the expression of several genes encoding proteins involved
in oxidative phosphorylation and mitochondrial biogenesis
(Mootha et al., 2004; Schreiber et al., 2004; Shao et al.,
2010), mitochondrial fusion (Russell et al., 2013), fatty
acid oxidation (Kamei et al., 2003; Schreiber et al., 2004),
oxidative muscle fiber phenotype (Rasbach et al., 2010), and
angiogenesis (Arany et al., 2008; Rowe et al., 2011) in skeletal
muscle. While a role in skeletal muscle differentiation and
regeneration has been described for ERRα (LaBarge et al.,
2014), its impact on skeletal muscle atrophy and effects
on protein turnover under normal or stress conditions
have not been well explored (reviewed in Huss et al., 2015).
Therefore, whether PGC-1α or PGC-1β can regulate protein
synthesis via the ERRα transcriptional pathway remains to be
established.
The present study aimed to determine whether PGC-
1α and/or PGC-1β can regulate protein synthesis in mouse
C2C12 myotubes under basal or catabolic conditions, and if
this is mediated via Akt/mTOR signaling, known stimulators
of protein synthesis in skeletal muscle (Bodine et al., 2001;
Rommel et al., 2001), or ERRα. Additionally, large-scale gene
expression profiling followed by bioinformatics analyses were
used to identify novel PGC-1α and PGC-1β regulated targets
that may influence muscle protein synthesis. Both an unbiased
and a biased selection of gene targets from the microarray
data were measured in skeletal muscle from a human model
of stimulated protein synthesis, acute resistance exercise, in
order to further characterize downstream genes influenced by
PGC-1α and PGC-1β during physiological changes to muscle
mass.
MATERIALS AND METHODS
Cell Culture
Mouse C2C12 myoblasts (American type culture collection;
ATCC, Manassas, VA, United States) were incubated at 37◦C
with 5% CO2, in 25 mM glucose Dulbecco’s Modified Eagle
Medium (DMEM) supplemented with 10% fetal bovine serum
and 1% penicillin streptomycin (PS) (Invitrogen, Carlsbad,
CA, United States). Myoblasts were plated at a density of
1.5 × 104/cm2 in 12-well plates. Upon confluence (∼48 h),
medium was changed to 25 mM DMEM supplemented with
2% horse serum (Invitrogen) and 1% PS for 4–5 days until
multinucleated myotubes had formed. Medium was replaced
every 48 h.
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FIGURE 1 | Protein synthesis and myotube diameter in GFP, PGC-1α, and PGC-1β infected C2C12 myotubes. (A) PGC-1α and (B) PGC-1β protein 72 h after
infection with GFP, PGC-1α, and PGC-1β adenoviruses. Bands were normalized to GAPDH protein; n = 4 per group. ∗∗∗P < 0.001 vs. GFP. (C) Protein synthesis
under basal and dexamethasone (DEX)-treated conditions, when measured for 24 h following 48 h of infection with GFP, PGC-1α, and PGC-1β adenoviruses.
n = 5–10 per group. ∗P < 0.05, ∗∗∗P < 0.001 vs. GFP within the same treatment; ###P < 0.001 vs. basal within the same condition. (D) Average myotube diameter
from 10 myotubes per visual field (10 visual fields for each group). ∗∗∗P < 0.001 vs. GFP. (E) Representative images of myotubes infected with GFP, PGC-1α, and
PGC-1β adenoviruses for 72 h.
Myotubes were infected with adenoviruses expressing
green fluorescent protein (GFP), PGC-1α or PGC-1β using a
multiplicity of infection (MOI) of 100. Cells were harvested
after 72 h for RNA, protein, and protein synthesis assays. For
experiments using ERRα knockdown, myotubes were infected
with an adenovirus expressing shRNA for ERRα (AdshERRα)
or its control, AdSUPER, using an MOI 200 (Schreiber et al.,
2003). After 24 h, myotubes were infected with an additional
dose of AdshERRα (or its control vector), as well as GFP,
PGC-1α, or PGC-1β at an MOI of 100. Cells were harvested
after 96 h for RNA, protein, and protein synthesis assays.
For experiments overexpressing a constitutively active ERRα,
myotubes were infected with an adenovirus expressing ERRα
with a heterogeneous strong transcriptional activation domain,
VP16-ERRα, or its control VP16-control, using an MOI of
100 (Schreiber et al., 2004). Cells were harvested after 72 h for
RNA, protein, and protein synthesis assays. Following infection
with GFP, PGC-1α, or PGC-1β adenoviruses, myotubes were
treated with 10 µM dexamethasone (DEX), 10 µM LY-294002, or
20 ng/mL rapamycin, which were obtained from Sigma-Aldrich
(St Louis, MO, United States), and their respective vehicle
controls, for 24 h.
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FIGURE 2 | Western blot analysis of Akt and p70S6k proteins in GFP, PGC-1α, and PGC-1β infected C2C12 myotubes. Myotubes were infected with GFP, PGC-1α,
or PGC-1β adenoviruses for 48 h, and samples were extracted after 72 h. (A) Phospho-Akt (ser473), (B) total Akt protein, (C) phospho-p70S6k (thr389), and
(D) total p70S6k protein expression. Samples were harvested after 72 h of infection. Bands were normalized to GAPDH protein. The same control images have been
used for A,C, and B,D. n = 5 per group. ∗P < 0.01 vs. GFP. (E) Protein synthesis in GFP, PGC-1α, and PGC-1β infected C2C12 myotubes, treated with LY294002
(LY294) or Rapamycin and compared to basal conditions. n = 6, repeated in three experiments. ∗∗P < 0.01, ∗∗∗P < 0.001 vs. GFP within the same treatment;
#P < 0.05, ###P < 0.001 vs. control within the same condition.
Protein Synthesis
Protein synthesis was determined by measuring the
incorporation of [3H]-tyrosine (Perkin Elmer, Boston, MA,
United States) into the myotubes (modified from Plaisance
et al., 2008). Following adenoviral infections, myotubes
were incubated in 1 µCi/mL of [3H]-tyrosine and 2 mM
L-tyrosine (Sigma-Aldrich). After 24 h, cells were washed
with cold phosphate buffered saline (PBS), and proteins
were harvested and precipitated in 10% trichloroacetic acid
(Sigma-Aldrich) on ice for one hour. Following centrifugation
at 20,000 × g for 10 min, the supernatant was removed
and the precipitates were dissolved in 0.1 M NaOH/1%
Triton X-100 overnight at room temperature. The samples
were mixed with Ultima Gold scintillation liquid (Perkin
Elmer) and myotube protein radioactivity was measured
using a Wallac 1409 DSA liquid scintillation counter
(Perkin Elmer). Counts were normalized to total genomic
DNA, which was extracted using the Allprep DNA/RNA
mini kit (Qiagen, Clifton Hill, VIC, Australia) as per the
manufacturer’s protocol. DNA was quantified using the
NanoDrop 2000 (NanoDrop Products, Wilmington, DE,
United States).
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Myotube Diameter
Myotubes were visualized using an Olympus IX70 microscope
(Olympus, Mt Waverly, VIC, Australia), and digital images
were obtained using a DS-U3 microscope camera and NIS-
Elements imaging software (Nikon Instruments Inc., Melville,
NY, United States). Approximately 10 myotubes from 10 fields
of view were analyzed for myotube diameter from each of the
different adenoviral infections.
RNA Extraction
RNA was extracted from C2C12 myotubes using Tri-Reagent
solution (Ambion Inc., Austin, TX, United States) according
to manufacturer’s protocol. RNA was extracted from human
muscle before and after resistance exercise using the To¯TALLY
RNATM Kit (Ambion Inc.). RNA quality and concentrations
were determined using the NanoDrop 2000 and Agilent 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA, United States)
for the C2C12 and human muscle samples, respectively.
RNA was reverse transcribed to complementary DNA (cDNA)
using a high-capacity cDNA reverse transcription kit (Applied
Biosystems, Forster City, CA, United States) according to
manufacturer’s protocol.
Semi-Quantitative Real-Time
Polymerase Chain Reaction (qRT-PCR)
Individual gene expression analysis was performed by qRT-PCR
using a Stratagene Mx3000P QPCR System and the MxPro
QPCR software (Stratagene, La Jolla, CA, United States). Cycling
conditions for the qPCR consisted of one denaturing cycle at
95◦C for 2 min, followed by 40 cycles of denaturing at 95◦C for
5 s and annealing at 60◦C for 20 s, and elongation at 72◦C for
60 s. Each 20 µL reaction contained 0.5 × Power SYBR Green
PCR Master Mix (Applied Biosystems), 25 ng of cDNA, and the
forward and reverse primers for the gene of interest. Primers were
designed using Primer 31 and the sequences crosschecked for
gene specificity using a BLAST search2. Primers were synthesized
by GeneWorks (Adelaide, SA, United States). Primer sequences
for the genes amplified in the qRT-PCR are in Supplementary
Table S1. To compensate for variations in input RNA amounts
and efficiency of the reverse transcription, data were normalized
to ribosomal protein, 36B4 (also known as RPLPO) mRNA.
Protein Extraction
Myotubes were lyzed in RIPA buffer (Merck-Millipore, VIC)
with 1 µL/mL protease inhibitor cocktail (Sigma-Aldrich) and
10 µL/mL Halt Phosphatase Inhibitor Single-Use Cocktail
(Thermo Scientific, Rockford, IL, United States). Protein
concentrations were determined using the bicinchoninic acid
(BCA) Protein Assay Kit (Thermo Scientific) according to
the manufacturer’s protocol, and absorbance was measured at
562 nm on a Synergy 2 Microplate Reader (BioTek, Winooski,
VT, United States).
1www.primer3.sourceforge.net
2https://blast.ncbi.nlm.nih.gov/Blast.cgi
Western Blotting
Electrophoresis was performed using a 4–12% NuPAGE R©
Novex Bis-Tris Gel (Invitrogen) in NuPAGE R© SDS MOPS
Running Buffer (Invitrogen). Protein transfer was performed
in a Bjerrum buffer containing 50 mM Tris, 17 mM glycine,
and 10% methanol using polyvinylidene difluoride (PVDF)
membranes (Merck-Millipore). The membranes were blocked
with 5% bovine serum albumin (BSA; Sigma-Aldrich) in PBS for
1 h, and incubated overnight at 4◦C with the following primary
antibodies diluted in 5% BSA in PBS: PGC-1α (Merck-Millipore);
PGC-1β (Novus Biologicals, Littleton, CO, United States); ERRα
(Epitomics, Burlingame, CA, United States); glyceraldehyde
3-phosphate dehydrogenase (GAPDH; Sigma-Aldrich);
Phospho-Akt (ser473), Akt, Phospho-p70S6k (thr389),
p70S6k, Phospho-4E-BP1 (Thr37/46), and 4E-BP1 (Cell
Signaling Technology, Danvers, MA, United States). All primary
antibodies were diluted 1:1,000, except for GAPDH which
was diluted 1:10,000. Following washing, the membranes were
incubated for 1 h with either IRDye R© 800CW Goat Anti-Rabbit
IgG (H+ L) (LI-COR Biosciences, Lincoln, NE, United States), or
Alexa Fluor R© 680 Rabbit Anti-Mouse IgG (H + L) (Invitrogen),
diluted 1:5,000 in PBS containing 50% Odyssey Blocking Buffer
(LI-COR Biosciences). Proteins were visualized on an Odyssey
Infrared Imaging System and densitometry was achieved using
Odyssey Application Software 3.0 (LI-COR Biosciences). All
blots were normalized to GAPDH protein. Full scans of entire
gels are included in Supplementary Figures S3–S5.
Microarray Analysis
The DNA microarray, data transformation, and ANOVA analyses
were performed by the Australian Genome Research Facility
(AGRF; Parkville, VIC, Australia). The quality and quantity of
the RNA extracted from the C2C12 myotubes overexpressed
with GFP, PGC-1α, and PGC-1β (a total of six samples for GFP
and PGC-1β, and three samples for PGC-1α) were determined
with the Agilent Bioanalyzer and RNA 6000 Nano Assay
kit (Agilent Technologies). A total of 500 ng of RNA was
labeled using the Total Prep RNA amplification kit (Ambion).
Labeled cRNA (0.05 µg/µL) was then combined with the
GEX-HYB Hybridisation Buffer in a 30 µL final volume and
hybridized to the Illumina Mouse-6v2 Expression Beadchip
(Illumina Inc., San Diego, CA, United States) overnight at
58◦C for 16 h. The chips were washed as outlined in the
Illumina manual, coupled with Cy3, and scanned in the
Illumina iScan Reader using GenomeStudio software (Illumina
Inc.). Raw signal intensity values were subjected to variance
stabilization transformation including background correction,
log2 transformation, and variance stabilization using the lumiR
package of R Bioconductor3 (Du et al., 2008; Lin et al., 2008).
ANOVA of normalized Illumina probe intensity values was
performed using Partek R© Genomic SuiteTM software, version 6.6
(Partek Inc., St. Louis, MO, United States). Pairwise comparison
of sample groups was performed using ANOVA. Differentially
expressed genes were selected by a change in expression level of
3www.Bioconductor.org
Frontiers in Physiology | www.frontiersin.org 5 September 2018 | Volume 9 | Article 1336
fphys-09-01336 September 22, 2018 Time: 15:19 # 6
Brown et al. PGC-1/ERRα Promote Protein Synthesis
FIGURE 3 | Protein synthesis and myotube diameter in C2C12 myotubes infected with AdshERRα and PGC-1 adenoviruses. Myotubes were infected with either
AdSUPER or AdshERRα for 24 h, followed by infection with GFP, PGC-1α, or PGC-1β for a further 48 h. (A) ERRα protein, normalized to GAPDH protein. n = 3–4
per group. (B) Protein synthesis, measured via [3H]-tyrosine incorporation for 24 hours after infections. n = 6 per group, repeated in three experiments. (C) Average
myotube diameter from 10 myotubes per visual field (10 visual fields for each group). (D) Representative images of GFP, PGC-1α, and PGC-1β infected myotubes,
with AdSUPER or AdshERRα. ∗∗∗P < 0.001 vs. GFP-AdSUPER. ##P < 0.01, ###P < 0.001 vs. AdSUPER for each condition. A.U., arbitrary units.
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FIGURE 4 | Western blot analysis of Akt and p70S6k proteins in C2C12 myotubes infected with AdshERRα and PGC-1 adenoviruses. Myotubes were infected with
either AdSUPER or AdshERRα for 24 h, followed by infection with GFP, PGC-1α, or PGC-1β for a further 48 h. Samples were harvested after 96 h. (A) Phospho-Akt
(ser473), (B) total Akt protein, (C) phospho-p70S6k (thr389), and (D) total p70S6k protein expression. Bands were normalized to GAPDH protein. The same control
images have been used for A–C. n = 4 per group. ∗∗P < 0.01, ∗∗∗P < 0.001 vs. GFP-AdShERRα; #P < 0.05, ##P < 0.01 vs. to AdSUPER for each condition.
at least 100% (fold-change > ± 1.5) in compared groups, and a
“nominal” ANOVA p-value< 0.05.
Bioinformatics Analysis of Microarray
Data
Gene set enrichment analysis (GSEA) was performed using
Database for Annotation, Visualization, and Integrated
Discovery (DAVID) v6.74 (Huang da et al., 2009a,b) on the
differentially expressed gene lists generated from the DNA
microarray. Gene Ontology (GO) terms5 were identified through
DAVID.
Unbiased, Discriminant Gene Selection
To identify a small subset of genes from the microarray
data that could optimally differentiate the response to PGC-
1α and PGC-1β overexpression, a combination of diagonal
linear discriminant analysis (DLDA) and the signal-to-noise ratio
(SNR) statistics (Stegmaier et al., 2004) was used as described
previously (Konstantopoulos et al., 2011). A DLDA algorithm
generated gene sets that classified arrays into each treatment
group. Using a forward step-wise variable selection, sets of
4http://david.abcc.ncifcrf.gov
5http://www.geneontology.org
genes from the dataset with optimal predictive power were
then identified and ranked according to their SNR statistic.
To eliminate genes that were co-regulated, Statistical Package
for the Social Sciences software (SPSS version 20.0, Fullerton,
CA, United States) was used to reduce signature genes to a
small subset that were discriminating and displayed divergent
expression profiles not highly correlated to each other. The
result of these analyses was the identification of a subset of
transcripts, similar to a gene expression signature (van de Vijver
et al., 2002), which best predict the effect of PGC-1α and
PGC-1β overexpression. Seven genes (four upregulated, three
downregulated) in this subset that were common to both PGC-
1α and PGC-1β regulation were then measured in skeletal muscle
samples from individuals following acute resistance exercise via
qRT-PCR.
Resistance Exercise
Eight untrained, but recreationally active, individuals
participated in the exercise component of the study.
Subject characteristics are presented in Supplementary
Table S2. Exclusion criteria included resistance training
within the past 6 months, medication, or a history of a
condition or illness that would present as a health risk during
strenuous resistance exercise. All experimental procedures
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involved in this study were formally approved by the
Deakin University Human Research Ethics Committee (EC
18-2004).
Experimental Design
Each subject in the exercise group completed a familiarization
session prior to the experimental protocol. During the session,
a 5 RM test was performed for each subject for the leg press,
squat (assisted by the Smith machine), and leg extension.
1 RM was then calculated using the Brzycki equation (1
RM = weight lifted (kg)/1.0278 [reps to fatigue × 0.0278]). The
familiarization session took place at least 7 days prior to the
trial to allow sufficient recovery time before the experimental
trial commenced. For the 24 h preceding exercise, and the day
of the trial, the subjects consumed a standard diet (20% fat,
14% protein, and 66% carbohydrate) and abstained from alcohol,
caffeine, tobacco, and additional exercise. On the morning of
the trial, subjects presented to the laboratory in a fasted state.
Following 30 min of supine resting, a muscle sample was collected
from the vastus lateralis under local anesthesia (xylocaine 1%)
by percutaneous needle biopsy technique modified to include
suction. Excised muscle tissue from each biopsy was immediately
frozen and stored in liquid nitrogen for later analysis. Following
5 min of light cycling for warm-up, subjects completed two sets of
8–12 repetitions of bilateral leg press, squat, and leg extension at
80% 1 RM. This was followed by a third set to voluntary fatigue,
also at 80% 1 RM. Subjects had 1 min rest between exercises and
3 min rest between sets. The intensity of this exercise protocol was
similar to other studies on resistance exercise (Louis et al., 2007;
Buford et al., 2009; Vella et al., 2012). Additional muscle samples
were collected at 2, 4, and 24 h following the exercise. Biopsies
were collected from separate incisions at least 2 cm distal from
previous sites.
Statistics
Statistical analyses for the cell culture experiments were
performed using either a student’s t-test, or a two-way ANOVA
followed by Tukey’s multiple comparisons test with the adjusted
P-value set to P < 0.05 (GraphPad Software, La Jolla, CA,
United States). A one-way repeated measure ANOVA with
a Bonferroni adjustment was used for the resistance exercise
samples. All data are presented as mean ± standard error of the
mean (SEM), unless otherwise stated.
RESULTS
PGC-1α and PGC-1β Increase Protein
Synthesis and Myotube Diameter in
C2C12 Myotubes
To overexpress PGC-1α and PGC-1β, C2C12 myotubes were
infected with adenoviruses expressing GFP (control), PGC-1α,
or PGC-1β. PGC-1α and PGC-1β overexpression led to a 2.2-
fold and 2.6-fold increase in PGC-1α and PGC-1β protein
levels, respectively (Figures 1A,B). To investigate the effect
of PGC-1α and PGC-1β overexpression on protein synthesis,
the incorporation of [3H]-tyrosine was measured over 24 h
following adenoviral infections. Protein synthesis was measured
under basal conditions or with DEX treatment to induce
catabolic stress (Long et al., 2001). Overexpression of PGC-1α
and PGC-1β increased the basal rate of protein synthesis by
∼20%, respectively, when compared to GFP (Figure 1C). DEX
treatment decreased basal protein synthesis by ∼15%, while
overexpression of PGC-1α or PGC-1β attenuated this effect.
Similarly, overexpression of PGC-1α and PGC-1β increased
myotube diameter (Figures 1D,E).
PGC-1α and PGC-1β Do Not Increase
Protein Synthesis via Activation of
Akt/mTOR Signaling
Activation of Akt/mTOR signaling promotes skeletal muscle
protein synthesis via phosphorylation of their downstream
substrates, p70S6k and 4E-BP1, enhancers of protein translation
initiation and elongation (Bodine et al., 2001; Rommel et al.,
2001). To investigate if the Akt/mTOR pathway is regulated
by PGC-1α or PGC-1β, protein expression of key proteins in
this pathway was measured. Overexpression of PGC-1α and
PGC-1β decreased the phosphorylation of Akt (Figure 2A) and
p70S6k (Figure 2C) by 40–50%. There was also a decrease
in total Akt protein with PGC-1α overexpression (Figure 2B),
but no changes in total p70S6k (Figure 2D). However, there
was no change in the phosphorylated or total levels of 4E-BP1
(Supplementary Figures S1A,B). To further investigate whether
Akt/mTOR signaling is involved in the PGC-1α- and PGC-
1β-induced stimulation of protein synthesis, myotubes were
treated with a PI3K inhibitor, LY294002, or an mTOR inhibitor,
rapamycin (Rommel et al., 2001; Latres et al., 2005). Compared
to the basal group, treatment with LY294002 and rapamycin
decreased protein synthesis similarly in the GFP, PGC-1α and
PGC-1β-infected myotubes (Figure 2E). These results show that
both PGC-1α and PGC-1β do not increase protein synthesis via
the activation of Akt/mTOR signaling in myotubes.
ERRα Is Involved in the PGC-1α- and
PGC-1β-Induced Increase in Protein
Synthesis
Many of the PGC-1α and/or PGC-1β-mediated effects on
skeletal muscle also involve their activation of ERRα (Mootha
et al., 2004; Schreiber et al., 2004; Shao et al., 2010). To
determine if ERRα is involved in the PGC-1α- and PGC-
1β-induced increase in protein synthesis, C2C12 myotubes
were infected with an adenovirus expressing shRNA for ERRα
(AdshERRα) or a control vector (AdSUPER), in combination
with GFP, PGC-1α, and PGC-1β adenoviruses. As expected
(Kamei et al., 2003; Mootha et al., 2004), PGC-1α and
PGC-1β overexpression increased ERRα protein expression
(Figure 3A). AdshERRα decreased ERRα protein by 87%
when compared to AdSUPER and prevented the increase in
ERRα protein expression that was seen with PGC-1α and
PGC-1β overexpression (Figure 3A). AdshERRα had no effect
on basal protein synthesis in the GFP-infected myotubes
(Figure 3B). However, when overexpressed with PGC-1α
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FIGURE 5 | Protein synthesis and myotube diameter in VP16-ERRα infected C2C12 myotubes. (A) ERRα protein, normalized to GAPDH protein. n = 4 per group.
(B) Protein synthesis, measured by [3H]-tyrosine incorporation for 24 h following 48 h of infection with VP16-control or VP16-ERRα adenoviruses. n = 6 per group,
repeated in three experiments. (C) Average myotube diameter from 10 myotubes per visual field (10 visual fields for each group). (D) Representative images of
myotubes infected with VP16-control or VP16-ERRα for 72 hours. ∗∗∗P < 0.001 vs. VP16-control. A.U., arbitrary units.
or PGC-1β, AdshERRα attenuated the PGC-1α- and PGC-
1β-induced increase in protein synthesis (Figure 3B). Similarly,
AdshERRα alone did not affect myotube diameter in the GFP-
infected myotubes but ameliorated the PGC-1α- and PGC-
1β-induced increase in myotube diameter (Figures 3C,D).
As it was shown that PGC-1α and PGC-1β reduced the
phosphorylation of Akt and p70S6k, their expression was also
measured to see if it was affected by knockdown of ERRα.
AdshERRα increased the phosphorylation of Akt in the GFP and
PGC-1α, but not the PGC-1β infected myotubes when compared
to the AdSUPER control (Figure 4A). There were no significant
changes in total Akt protein, phosphorylated p70S6k, or total
p70S6k protein (Figures 4B–D), or in phosphorylated or total
4E-BP1 (Supplementary Figures S1A,B).
Constitutively Active ERRα Increases
Protein Synthesis and Myotube Diameter
To further support the role of ERRα in positively regulating
protein synthesis, C2C12 myotubes were infected with a
constitutively active form of ERRα (VP16-ERRα), or its
control (VP16-control). VP16-ERRα increased ERRα protein
levels by approximately 4.5-fold (Figure 5A). VP16-ERRα
increased protein synthesis by 52% compared to VP16-control
(Figure 5B), which resulted in an increase in myotube
diameter (Figures 5C,D). Lastly, VP16-ERRα decreased Akt
and p70S6k phosphorylation (Figures 6A,C), and total Akt and
p70S6k protein (Figures 6B,D) but did not change total or
phosphorylated 4E-BP1 (Supplementary Figure S1B).
Microarray and GSEA
A global overview of genes significantly regulated following
PGC-1α and PGC-1β overexpression revealed 1,035 and
3,090 genes, respectively, that displayed at least a 1.5-fold
increase or decrease in mRNA levels when compared to
the GFP control group (Supplementary File S1). As both
PGC-1α and PGC-1β enhanced protein synthesis, the genes
contributing to protein synthesis activity are likely to be
common to both the transcriptional coactivators. Intersect
analyses of each gene list (restricted to twofold mRNA change)
revealed that 299 genes were commonly regulated by both
PGC-1α and PGC-1β (Supplementary File S2). These genes
were next submitted to GSEA and revealed genes clustered
significantly with 94, 37, and 40 biological process, cellular
compartment and molecular function GO terms, respectively
(Supplementary File S3). Predominantly, GO terms relating
to mitochondria and metabolism were identified; however,
genes were enriched significantly in multiple biological process
GO terms including energy metabolism (biosynthetic and
catabolic), oxidation–reduction, ion transport and homeostasis,
apoptosis, muscle development, and translation. For the cellular
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FIGURE 6 | Western blot analysis of Akt and p70S6k proteins in VP16-ERRα infected C2C12 myotubes. Myotubes were infected with VP16-control or VP16-ERRα
adenoviruses for 48 h, and samples were extracted after 72 h. (A) phospho-Akt (ser473), (B) total Akt protein, (C) phospho-p70S6k (thr389), and (D) total p70S6k
protein expression. Bands were normalized to GAPDH protein. The same control images have been used for A,B. n = 5 per group. ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001 vs. VP16-control.
compartment, genes associated with GO terms primarily linked
with the mitochondrion, in particularly the mitochondrial inner
membrane and lumen, in addition to significant associations
identified with the ribosome and myofibril/contractile fiber.
Furthermore, the molecular function GO terms revealed the
majority of gene associations with metabolically related cofactor
binding and enzyme activities in addition to translation
elongation factor activities and the structural constituent of
ribosome. A summary of the biological processes, cellular
compartments, and molecular functions linked with GO terms
is presented in Figure 7. Together, these terms indicate
dynamic metabolic, structural, and translational processes
occurring in C2C12 myotubes following PGC-1α or PGC-1β
overexpression.
Biased Selection of Genes From the
Microarray
To elucidate possible molecular mechanisms by which PGC-
1α and PGC-1β regulate protein synthesis, a selection of genes
that were upregulated or downregulated by both transcriptional
coactivators as revealed by microarray analyses was explored
further. The genes and their related GO terms chosen are
shown in Table 1. Most of the upregulated genes are linked
to translation GO terms, while other genes that are linked
to apoptosis and cell homeostasis GO terms are primarily
downregulated as well as genes associated with protein processing
and proteolysis, transcription, or the negative regulation of
skeletal muscle tissue development. The expression of these
genes was validated via qRT-PCR (Figure 8). Overexpression
of PGC-1α or PGC-1β led to increased gene expression for
eukaryotic translation elongation factor 1 alpha 2 (Eef1a2),
eukaryotic translation initiation factor 2B, subunit 4 (Eif2b4),
and eukaryotic translation initiation factor 4E family member 3
(Eif4e3) (Figure 8A). In contrast, caspase 1 (casp1), transcription
elongation factor A SII-like 7 (Tceal7), TSC22 domain family
protein 3 (Tsc22d3), and prion protein (Prnp) were all
decreased in response to PGC-1α and PGC-1β overexpression
(Figure 8B).
Unbiased Selection of Genes From
Microarray Data
Statistical analyses of the entire microarray data set revealed
seven discriminant genes significantly regulated (P < 0.05)
by PGC-1α and/or PGC-1β (Table 2). The expression
of these targets was validated via qRT-PCR (Figure 8).
Overexpression of PGC-1α or PGC-1β increased the mRNA
of protein phosphatase 1, regulatory subunit 16A (Ppp1r16a),
mitochondrial ribosomal protein sub-unit 9 (Mrps9), TAR
HIV-1 RNA binding protein 2 (Tarbp2), and cell division
cycle 14 homolog B (Cdc14b) (Figure 8C). In contrast,
exocyst complex component 1 (Exoc1), tripartite motif-
containing protein 25 (Trim25), and tripartite motif-containing
protein 32 (Trim32) were downregulated (Figure 8D).
Although microarray analyses revealed Trim25 and Trim32
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as regulated separately by PGC-1β and PGC-1α, respectively,
the expression of these genes was reduced in response to
both PGC-1α and PGC-1β overexpression when measured via
qRT-PCR.
Regulation of Genes in a Model of
Muscle Hypertrophy
Resistance exercise in the young and elderly increase protein
synthesis rates (Yarasheski et al., 1993). Similar to previous
studies, PPARGC1A mRNA was increased transiently at 2
and 4 h following resistance exercise (Deldicque et al., 2008),
and then reduced after 24 h (Supplementary Figure S2A).
In contrast, PPARGC1B mRNA was decreased at 4 and
24 h post-exercise (Supplementary Figure S2B). This was
FIGURE 7 | Overview of the GSEA performed on genes commonly regulated
by both PGC-1α and PGC-1β in C2C12 myotubes. Proportional
representation of gene numbers significantly enriched in GO-related (A)
biological processes, (B) cellular compartment, and (C) molecular functions
with the number of genes indicated in brackets. The proportion of genes
making up the specific sub-groups; CC GO term mitochondrial inner
membrane, and MF GO terms translation elongation factor activity are also
indicated.
associated with significant increases in EEF1A2, EIF2B4, and
EIF4E3 genes at 2 h post-exercise (Figure 9A). After 24 h,
the expression of EIF2B4 increased further, while EEF1A2
and EIF4E3 mRNA expression returned to, or was slightly
below, pre-exercise levels. Of the selected genes that were
downregulated in the microarray, only TSC22D3 was decreased
following resistance exercise, while CASP1 and PRNP were
increased 24 h post-exercise (Figure 9B). Of the genes
selected unbiasedly from the microarray, PPP1R16A and
CDC14B were also increased following resistance exercise
(Figure 9C), while EXOC1 and TRIM32 were decreased
(Figure 9D).
DISCUSSION
Understanding the molecular mechanisms that regulate protein
synthesis in skeletal muscle is essential for developing therapeutic
interventions to combat muscle atrophy. PGC-1α and PGC-
1β are downregulated in many models of muscle atrophy
characterized by protein degradation processes greater that
protein synthesis, and potentially by mitochondrial dysfunction.
Here, we demonstrate that PGC-1α or PGC-1β overexpression
increases protein synthesis and myotube diameter, independent
of Akt and mTOR signaling, but requiring ERRα. Interestingly,
PGC-1α or PGC-1β overexpression was able to restore protein
synthesis to control levels following treatment with DEX, a
catabolic agent known to reduce protein synthesis and myotube
diameter. Whether PGC-1α or PGC-1β overexpression can
restore myotube diameter following DEX treatment remains
to be determined but warrants future investigation to further
understand their role in regulating myotube hypertrophy.
A similar cell culture model to the current study previously
observed that PGC-1α and PGC-1β attenuated protein
degradation, but with no effect on protein synthesis (Brault
et al., 2010), although protein turnover was measured for only
2 h following 24 or 48 h of adenoviral infection. The results
from the present study, however, show that overexpression of
PGC-1α or PGC-1β increased protein synthesis throughout the
24 h following a 48 h adenoviral infection; an effect observed
under both basal and DEX-treated conditions. This finding
suggests that protein synthesis may need to be measured over
a longer period of time in order to detect effects by PGC-1α or
PGC-1β overexpression. Alternatively, variable levels of PGC1
protein overexpression between the studies may account for
the differences. Brault and others also normalized their protein
synthesis values against total protein content, which may off-set
any increase in protein synthesis from PGC1 overexpression.
Interestingly, here and in other studies (Mortensen et al., 2007;
Mathai et al., 2008), human PGC-1β levels in skeletal muscle were
decreased following resistance training. However, transgenic
mouse studies have reported PGC1β overexpression to replicate
an exercise training response in sedentary mice (Lee et al., 2017).
Currently, it is unclear of the impact of reduced PGC-1β levels in
exercised human muscle.
The Akt and mTOR signaling pathways are well
known regulators of protein synthesis in skeletal muscle
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TABLE 1 | Genes and their Gene Ontology (GO) terms selected biasedly from the microarray.
Fold-change to GFP
Gene PGC-1α PGC-1β GO terms
Eef1a2 10.9 19.6 GO:0006412: translation
GO:0043067: regulation of programmed cell death
Eif2b4 1.6 2.6 GO:0006412: translation
GO:0042592: homeostatic process
Eif4e3 1.9 1.9 GO:0006412: translation
GO:0042592: homeostatic process
Casp1 −1.8 −2.2 GO:0043065: positive regulation of apoptotic process;
Tsc22d3 −1.5 −2.5 GO:0048642: negative regulation of skeletal muscle tissue development
Prnp −1.6 −2.6 GO:0042592: homeostatic process
GO:0043067: regulation of programmed cell death
Tceal7 −4.6 −8.4 GO:0006351: transcription, DNA-dependent
(Bodine et al., 2001; Rommel et al., 2001). In this study,
however, PGC-1α and PGC-1β decreased Akt and p70S6k
phosphorylation; the latter activated by mTOR. Furthermore,
Akt or mTOR activity inhibited by LY294002 and rapamycin,
respectively, was not required for PGC-1α or PGC-1β to increase
protein synthesis, nor was increased phosphorylation of 4E-
BP1, suggesting the activation of alternate protein translation
pathways. Many of the PGC-1α- and PGC-1β-mediated effects
in skeletal muscle require ERRα transcriptional activity (Mootha
et al., 2004; Schreiber et al., 2004; Shao et al., 2010), and as shown
here, knockdown of ERRα prevented the PGC-1α- and PGC-
1β-induced increase in protein synthesis and myotube diameter
and with no effect during basal conditions suggesting that ERRα
may only be involved in the regulation of protein synthesis
when stimulated by PGC-1α or PGC-1β. These observations
support the role for ERRα as a latent transcription factor, which
FIGURE 8 | mRNA expression of genes identified from the microarray based on their GO terms involved with protein synthesis, translation, and growth. Myotubes
were infected with GFP, PGC-1α, or PGC-1β adenoviruses for 48 h, and samples were extracted after 72 h. mRNA of biasedly selected genes that were
(A) upregulated and (B) downregulated in the microarray. mRNA expression of the genes selected unbiasedly from the microarray that were most significantly
(C) upregulated and (D) downregulated. Values were normalized to 36B4 mRNA expression. n = 3, repeated in three experiments. ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001 vs. GFP.
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TABLE 2 | Microarray profile of the most significantly regulated genes by both PGC-1α and PGC-1β overexpression.
Gene GenBank accession no. Direction vs. GFP PGC-1α P-value PGC-1β P-value
Ppp1r16a NM_033371.2 Up 0.001 5.77E-11
Mrps9 NM_023514.3 Up 6.61E-06 4.35E-12
Tarbp2 NM_009319.1 Up 9.03E-04 3.30E-11
Cdc14b NM_172587.2 Up 0.018 2.76E-10
Exoc1 NM_027270.1 Down 8.04E-05 6.35E-12
Trim25∗ NM_009546.2 Down 5.15E-09
Trim32∗∗ NM_053084.1 Down 0.001
∗PGC-1β only; ∗∗PGC-1α only.
is only active when partnered with coactivators such as PGC-1α
and PGC-1β (Schreiber et al., 2003). The effects of ERRα on
protein synthesis were further supported by expression of a
constitutively active ERRα (VP16-ERRα) resulting in a large
increase in protein synthesis. Other than the roles ERRα plays
in muscle repair and regeneration (LaBarge et al., 2014), our
finding of ERRα’s promotion of protein synthesis in skeletal
muscle cells is novel and the mechanism of how it occurs requires
further study. Insight into this mechanism is taken potentially
from studies which have already observed a molecular cross-talk
between mTOR and ERRα in other cell types and conditions.
These include synergism observed between rapamycin and
inhibition of ERRα during lipid metabolic activities in fatty liver
(Chaveroux et al., 2013), T cell activation (Michalek et al., 2011),
and following induction of tumorigenesis in oral squamous cell
carcinoma cells (Gan et al., 2017). Similar to PGC-1α and PGC-
1β overexpression, the phosphorylation and expression of Akt
and p70S6k were inhibited by VP16-ERRα providing additional
evidence that PGC-1α and PGC-1β do not increase protein
synthesis via activation of Akt/mTOR signaling. The lack of
Akt/mTOR activation measured here may reflect the longer-term
impact of PGC-1α, PGC-1β, and VP16-ERRα overexpression
as endpoint measurements were made 72 h post-viral infection.
This time-frame may allow for alternate molecular adaptations
to promote protein synthesis including mitochondrial and
ribosomal biogenesis as indicated in the GSEA findings.
FIGURE 9 | mRNA expression of genes selected from the microarray in skeletal muscle after an acute bout of resistance exercise in humans. Muscle samples were
taken before and 2, 4, and 24 h after resistance exercise. (A) Upregulated genes and (B) downregulated genes selected biasedly; and (C) upregulated genes and
(D) downregulated genes selected unbiasedly from the microarray. Values were normalized to 36B4 mRNA expression. n = 8. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001
vs. Pre-exercise (Pre).
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To highlight novel PGC-1α- and PGC-1β-regulated targets
that may influence muscle protein synthesis and to extend
our knowledge of the molecular adaptations occurring with
PGC-1α or PGC-1β overexpression, large-scale gene expression
profiling using microarray analyses was performed. The GSEA
revealed GO terms associated with biosynthetic and catabolic
processes, mitochondria, muscle tissue development, ribosomal
and translational activities, supporting the concept of active
protein synthesis and metabolic adaptations occurring in the
C2C12 myotubes. Enhanced protein synthesis in response to
PGC-1α or PGC-1β overexpression may be in part due to the
generation of mitochondrial- and metabolic-related proteins,
which support known roles for PGC-1α and PGC-1β in
mitochondrial biogenesis and function (Wu et al., 1999; St-
Pierre et al., 2003; Schreiber et al., 2004; Soriano et al., 2006;
Benton et al., 2008; Liesa et al., 2008; Espinoza et al., 2010;
Shao et al., 2010). Interestingly, other genes identified in our
microarray screen may also be linked to protein synthesis,
but independent of mitochondrial biogenesis (Supplementary
File S2). One such gene is the N-myc downstream-regulated gene
2 (Ndrg2), which we previously identified as a target of PGC-
1a/ERRa transcriptional regulation (Foletta et al., 2013). The
suppression or overexpression of Ndrg2 increased and decreased
protein synthesis, respectively, without altering the expression of
gene markers of mitochondrial biogenesis (Foletta et al., 2013).
Therefore, these GO terms further indicate roles for PGC-1α and
PGC-1β in protein synthesis related to both mitochondrial and
non-mitochondrial processes in C2C12 myotubes.
Supporting their potential role in protein synthesis, PGC-1α
and PGC-1β overexpression increased the mRNA of elongation
and translation initiation factor genes including Eef1a2, Eif2b4,
and Eif4e3. Interestingly, these were genes also increased in
skeletal muscle following resistance exercise. Deletion of Eef1a2
due to a spontaneous mutation has been shown previously to
result in severe muscle wasting and weakness in mice (Chambers
et al., 1998; Newbery et al., 2005), and is a key factor in muscle
protein translation following denervation (Doig et al., 2013)
further suggesting a role for Eef1a2 in muscle mass control.
A number of the discriminant genes unbiasedly selected also
shows links to the regulation of protein synthesis and atrophy.
For example, Trim32 encodes an E3 ubiquitin ligase that degrades
thin myofibrillar contractile proteins during muscle atrophy
(Cohen et al., 2012), and in humans, is upregulated in muscle
of patients with DMD (Assereto et al., 2016). PGC-1α and PGC-
1β are known to attenuate skeletal muscle protein degradation
by downregulating other ubiquitin ligases, Atrogin-1 and Muscle
Ring Finger-1 (Brault et al., 2010) and, therefore, may also
target Trim32 is this process. Furthermore, TARBP2 contributes
the control of protein synthesis during spermatogenesis (Braun,
2000), but whether it does in skeletal muscle processes remains to
be investigated. Additional studies are required to determine the
interaction between PGC-1 proteins and these genes, and their
effect on protein synthesis in skeletal muscle.
CONCLUSION
This study has shown for the first time that the transcriptional
coactivators, PGC-1α and PGC-1β, can increase protein synthesis
and myotube hypertrophy in C2C12 myotubes; a response
independent from the Akt and mTOR signaling pathways, but
dependent on ERRα. While the large-scale identification of novel
downstream targets regulated by PGC-1α and PGC-1β provides
insight into how these coactivators regulate skeletal muscle
growth and metabolic adaptations, the challenge is now to dissect
the interplay of these targets to help promote the anabolic effects
of PGC-1α and PGC-1β.
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